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More  than  500  papers  are  retrieved  from  the  PubMed  database  by the  keywords  “Tobacco”  and  “Otorhin-
olaryngology”,  none  of which,  however,  is  devoted  to the  history  of  a  plant  that  has  a major  impact  on
our  specialty  and  practice.  The  present  report  describes  and  analyzes  how  tobacco  conquered  the  world,
the conﬂicts  it triggered  and  the  impact  it has  had  in  our  ﬁeld  over  the  past  centuries.. In the beginning, revelation
In the late 15th century, the Spanish, followed by the Portuguese,
ame across tobacco in the New World. On October 28, 1492, on
he eastern coast of Cuba, Columbus’s crewmen noticed Arawaks
nhaling the smoke of a dried herb. In a semantic shift, “tabaco”
 which, in the native language referred to the pipe – was adopted
y the Spaniards for the contents of the pipe, and then for the plant
tself [1–4]. Eight years later, Alvarez Cobral landed in Brazil, and
he historian Pêro vas da Caminha gave the name “pétun” to the
obacco that the Tupi in the region of Rio de Janeiro smoked and
alled “petyn” in their language [1–4].
The ﬁrst tobacco seeds reached Spain in 1520, and the physician
f King Phillip II was able to conﬁrm the virtues the native Ameri-
ans claimed for the plant: appetite suppressant, mood enhancer,
sychostimulant and local anesthetic [1,2]. In 1550, the Spanish
ntroduced tobacco in the Low Countries. The Ottoman Empire dis-
overed it in 1560, Morocco in 1593 (via the Sudan, seeds having
een exported to Africa by Portuguese merchants) [2]. Tobacco
eeds were taken to Japan by Christian missionaries in 1596, while
rench Huguenot refugees “contaminated” the Holy Roman Empire
2].
Several individuals were involved in the subjugation of France.
n 1552, André Thevet (Fig. 1), then chaplain of an expedition to
ound a colony in the bay of Rio de Janeiro, rediscovered “pétun”
1,2]. He was driven back to France in 1556 by an outbreak of plague
nd, among other curiosities, brought back seeds that he planted
nd grew near Angoulême [1,2]. A few years later, in 1561, Jean
∗ Corresponding author. Tel.: +33 01 56 09 3463.
E-mail address: ollivier.laccourreye@egp.aphp.fr (O. Laccourreye).
http://dx.doi.org/10.1016/j.anorl.2013.11.003
879-7296/© 2014 Elsevier Masson SAS. All rights reserved.© 2014  Elsevier  Masson  SAS.  All  rights  reserved.
Nicot (Fig. 2), then French ambassador to Portugal, came into con-
tact with “tabaco”; some say he planted seeds he had got from a
Flemish merchant in the embassy garden in Lisbon, others that a
Portuguese market-gardener supplied him with a powder of dried
leaves [1,4]. He wrote to the Cardinal of Lorraine, who  was  close
to the Queen of France: “I have come into possession of an herb
of the Indies, marvelous and proven force against the Noli Me Tan-
gere and ﬁstulae despaired incurable by physicians and a singular
prompt remedy to nausea. When so it shall have seeded I will dis-
patch the same to a gardener in Marmoustier and place some of
the plant in a barrel to be replanted and maintained likewise as I
have for the orange trees” [2]. According to historians, Catherine
de’ Medici and/or her son Francis II soothed their headaches with
the plant, and the entire Court thus adopted this “Queen’s herb” or
“Catherinary herb”, taken in the form of snuff [2,5]. In 1586, in his
Historia Generalis Plantarium, the physician and botanist Jacques
Daléchamps (Fig. 3) named in “Nicotiana”, for Jean Nicot, much
to the annoyance of Thevet, who expostulated: “I was  the ﬁrst in
France that brought the seeds of this plant and also that planted and
did name the same “herb of Angoulême”. Since what time, a triﬂer,
that never was  of the voyage, some ten years after my  return to this
land, has given it his name!” [2].
In Virginia, as of 1610, Sir Walter Raleigh began tobacco farm-
ing with labor imported via the Triangular Trade between Europe,
Africa and the Americas [2]. Thereafter, it spread throughout all
strata of society. In France under Louis XIII, tobacco was selling
for 12 sous a pound in the form of “carrots” that could be grated,
chewed or crumbled for smoking [1] (to this day in France, tobac-
conists’ shop-fronts are distinguished by a sign in the form of a long
red lozenge, based on two  “carrots” joined at their tops [2]).
Only in 1809 did Louis Nicolas Vauquelin, professor of chem-
istry at the Medical School of Paris, isolate a volatile alkaline active









wFig. 1. André Thevet.
rinciple in tobacco leaf juice [5]. In 1828, Posell and Reimann, in
he University of Heidelberg, puriﬁed this psychoactive substance,
nd named it nicotine [5]. Nicotine induces addiction and habit-
ation and has insecticidal and fungicidal properties that protect
he plant against insects and certain forms of parasitosis. It is toxic
hen ingested orally – a single cigar contains double the lethal dose
f 40 to 60 mg  – and its ﬁrst proven use as a murder weapon dates
rom 1851 [5,6]. Its metabolism and interaction with dopamine
ere described in 1950 [1].
Fig. 2. Jean Nicot.Fig. 3. Jacques Daléchamps.
2. Growth and development
Several factors militated in favor of tobacco’s conquest of the
world. Initially, its medical reputation was  seductive. Add to that
the power of fashion and addiction combined with the search for
proﬁt on the part of industry and the State did the rest.
A look at the list of the virtues that physicians and men  of
science at ﬁrst attributed to tobacco is enough to explain the enthu-
siasm. Ambroise Paré, for example, recommended local application
of the “Catherinary herb” for wounds, and inhalation as a precau-
tion against plague [7]. The physicist René Ferchaud de Réaumur
suggested it would be useful in resuscitating victims of drowning,
and for Trousseau it had the same properties as solanaceae such as
datura inasmuch as he had relieved one of his asthma attacks with
a few drags on a cigar [7]. In the ﬁeld of ENT, Diderot’s Encyclopédie
explained that, in the form of snuff, tobacco “causes an agree-
able titillation of the nerves of the pituitary membrane”, Voltaire
asked “Was tobacco made for the nose or the nose for tobacco?”
and Trousseau advised fumigations of tobacco to treat laryngeal
phthisis [1,7,8].
Fashion played just as great a role. For courtiers and artists, the
use of tobacco was  de rigueur, and this positive image would last
into the mid-19th century. In 1665, in Molière’s Don Juan, Sganarelle
says of tobacco: “It delights the honest man, and whoever lives
without tobacco is not worthy of living.” Queen Marie-Antoinette’s
wedding chest contained 52 snuff-boxes (all in gold!), while
Frederick I of Prussia founded an Academy of the Pipe [2]. Locke
and Newton were both smokers, Johann Sebastian Bach wrote a
tobacco cantata, and Kant, Voltaire, Pope, Schiller, Musset, Baude-
laire and Georges Sand to name but a few praised the beneﬁts of the
herb [2]. Freud later said, “I owe  to the cigar a great intensiﬁcation
of my  capacity to work and a facilitation of my  self-control” [9].
The poor also seized on the herb. Beggars smoked “papelitos”:
scraps of tobacco rolled up in a vegetable envelope then in paper.
This ancestor of the cigarette appeared in the 16th century in Spain
and her colonies, and Napoleon’s troops adopted it during the
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he ﬁghting [1,2]. In 1842, in the “Gros Caillou” (“Big Stone”!) factory
n Paris, the French state tobacco monopoly produced the ﬁrst real
igarette, ﬁve years before Philip Morris set up his ﬁrst cigarette
actory in Oxford and a tobacconist’s in London [1,2]. These early
igarettes were hand-made by a female workforce, and productiv-
ty was low. Then in 1883 in Richmond, Virginia, James Bonsack
lashed costs by inventing, at the age of 18, a machine that could
urn out 120,000 cigarettes a day – the equivalent of 48 female
actory-hands of the time [1–4]. Nowadays, automated machinery
hurns out more than 8,000 cigarettes per minute. . . The geogra-
hy of manufacture has also shifted: in the early 19th century, 70%
f world production was concentrated in the USA; by 2011, this was
own to 4%, far behind China’s 42% of a worldwide total estimated
t some 8 million tons of tobacco leaf [10].
During the 17th century, the Exchequers of Europe quickly
eveloped a taste for the income tobacco could bring in. In Britain,
ames I introduced a tobacco tax in 1604, although by hiking cus-
oms duties by 82 pence per pound he also promoted the cause
f smuggling. Even so, he was soon followed by Spain, Venice,
he Papal States, the Austrian Empire, Poland and Russia [4]. In
rance, Richelieu introduced a “duty on pétun and tobacco” in 1629
2]. In 1681, Colbert declared a royal monopoly on what was  the
argest production in Europe, with plantations in eastern and south-
estern France and the French West Indies [2]. The Revolution of
789 abolished the monopoly and deregulated sale and production
2]. In a Thermidorian reaction, in 1811, Napoleon restored taxation
nd monopoly [2] – a move which no subsequent French regime
as ever to go back on. In 1864, the Civil War  gave the American
ederal Government a good excuse to ﬁll its coffers with a tobacco
ax [4]. Later, in 1921, Iowa introduced the ﬁrst State tobacco tax,
o balance its budget [4]. With the 1929 Crash and the ensuing
epression, all the other States followed suit [4]. The private sector
as never far behind: in 2008, with more than a billion smokers
orldwide (including more than 15 million in France), 90% of the
arket was in the hands of 5 companies, 4 of them private, with
nnual earnings exceeding $300 billion (more than 160 billion of
hich were handed over to the State) and net proﬁts (after tax) of
ore than $14 bn [11,12]. According to the World Health Organiza-
ion, the tobacco industry decided in the 1990s to target emerging
ountries and the youngest age-groups, investing tens of billions of
ollars yearly to do so [13,14].
. Hazards and conﬂicts
No sooner was it discovered than tobacco was sparking conﬂict.
n 1498, Columbus’s companion Rodrigo de Jerez, who had taken
o smoking with the natives, was hauled before the Inquisition for
aving smoked in public in Barcelona: he was accused of Satanism
ecause of the smoke that came out of his nostrils and was  thrown
nto prison [3]. In England, Henry VIII had smokers whipped and his
aughter Elizabeth conﬁscated pipes and snuff-boxes [2,4]. James
 went on to outlaw tobacco-growing and published an anony-
ous pamphlet entitled A Counter-Blaste to Tobacco in which he
sked how the brain, being naturally cold and humid, could sup-
ort inhalation of hot dry smoke, clogging the whole body with its
oot. Smoking was a ﬁlthy, stinking and ruinous habit, creating a
erilous addiction and a drunkenness like that of wine, “loathsome
o the eye, hateful to the nose, harmful to the brain, dangerous to
he lungs, and in the black stinking fume thereof, nearest resem-
ling the horrible Stygian smoke of the pit that is bottomless” [15].
entenced to death by him, Sir Walter Raleigh mounted the scaffold
ith his Indian pipe in Virginian Maplewood between his lips [1].
he Pope was not to be outdone: in 1642, Urban VII excommuni-
ated several hundred priests who were in the habit of smoking at
ass, as they “sully the sacred cloth with the disgusting humorslogy, Head and Neck diseases 131 (2014) 183–188 185
that tobacco causes and infect our temples with a repugnant odor”,
and in 1650 all those who  “touch the Devil’s herb” were threatened
with excommunication by Innocent X because cigar and pipe smoke
was masking the perfume of the incense and causing certain monks
to cough in the middle of hymns [1–3]. In Russia, after a smoker had,
in 1634, set off a ﬁre that destroyed many of the wooden houses of
Moscow, Tsar Mikhail Fedorovitch Romanov I decreed that dealers
should be whipped, smokers caned on the soles of their feet and
repeat offenders beheaded [2]. In the East, anti-smoking measures
were even more radical. Sultan Murad IV had smokers hanged while
Shah Abbas arranged for the punishment to ﬁt the crime, cutting
their nose or lips off, and his successor, Saphi, had them impaled,
with dealers punished by having molten lead poured down their
throats [2]. In Arabia, under Ben-abd-el-Wahad, when a cholera
epidemic struck the country, the Wahabites declared it was  divine
retribution due to tobacco smokers, who were duly massacred in
larger numbers than the epidemic itself had accounted for [1].
As tobacco began to be used for non-medical purposes, doubts
arose as to its harmlessness. When Jacques Cartier landed on
Montreal Island, the Amerindians offered him tobacco; he wrote
in his diary, “We  tried to imitate them but the smoke burned our
mouths as if it had been pepper” [3]. As early as 1659, Dr. Everard
was wondering whether this “noble herb” might not also have “the
power to shorten our lives” [1]. In 1761, the English physician John
Hill published what may  be claimed to be the ﬁrst article impli-
cating tobacco in cancer, Against the immoderate use of snuff [3]. In
1681, Simon Paulli, physician to the King of Denmark, claimed in his
treatise on the abuse of tobacco and tea that “tobacco when smoked
spoils the brain and blackens the skull” [16]. Gui-Crescent Fagon,
physician to Louis XIV and protégé of Madame de Maintenon,
published around 1710 a memoir entitled The inconveniences of
tobacco, but unfortunately entrusted the public reading of it to a
courtier who was happily snifﬁng the stuff throughout the pre-
sentation! [2,3]. In 1862, the minutes of the Académie des sciences
mention a case of heart attack following smoke inhalation [1]. Dr
Paul Jolly, a member of the French National Academy of Medicine,
wrote in 1882 that “Smoking should be ranked at the same level
as tuberculosis, alcoholism and syphilis as a scourge of society”
[1,17]. Three years later, the French Association Against the Use of
Tobacco, of which Pasteur was  a member, was  founded [1]. Writers
took up the cause: Alexandre Dumas (ﬁls) declared, “Tobacco in
my opinion, together with alcohol, is the most formidable enemy
of intelligence, but nothing will destroy the abuse, imbeciles being
the most numerous and tobacco having nothing to destroy in
them”, while according to Balzac “Tobacco destroys the body,
damages the mind, and stupeﬁes nations”, and for Victor Hugo
“Tobacco changes thought into dream. Thought is the labor of
the intellect: dream is its pleasure. Woe  to him who falls from
thoughts into dreams. To replace thought by dreams is to mingle
a poison with nourishment” [18]. In the United States, Lucie Page
Gaston founded the Anti-Cigarette League of America in December
1899, and Henry Ford became one of its ﬁrst members [4].
It was  during the 20th century that scientiﬁc proof of the harm-
fulness of tobacco accumulated. In 1901, tobacco was designated
an “industrial poison” by the French Labor Bureau, and in 1903 the
Canadian parliament considered a total ban on cigarettes [3,19]. In
the same period, various studies appeared on the dependence and
addiction (both of which had actually been described by Sir Francis
Bacon in 1623) induced by nicotine [20]. In France, several med-
ical theses denounced the otorhinolaryngologic perils of tobacco
[17]. The Great War, however, pushed this into the background:
the troops needed cigarettes to keep up their morale [1]. In 1928, in
the inter-war years, the New England Journal of Medicine reported
a cohort of 217 cancer patients, pointing out that those suffering
from cancer of the lung, lip, jaw, cheek and to a lesser degree lar-
ynx were almost systematically heavy smokers [21]. The medical
































ommunity’s attention was also drawn to the very steep rise in
he incidence of lung cancer. While exhaust fumes and asphalt
ere widely incriminated, in 1939 an American surgeon, Alton
chsner, published an article implicating smoking [22]. Meanwhile,
n Germany, the ﬁrst epidemiological studies linking lung cancer
nd smoking were beginning to appear, highlighting the associ-
ted vascular complications [23,24]. As a result, in 1942, German
omen were banned from smoking or buying tobacco and the
ation handed out to German soldiers was reduced. In the post-
ar period, these studies, which had been conducted under the
uspices of the Nazi party in a spirit of “racial puriﬁcation”, went
iscreetly unmentioned. But in 1950 several English-language epi-
emiological studies relating smoking to lung cancer revived the
ebate [25–27]. They ran up against a great deal of skepticism
romoted by the tobacco companies’ intensive lobbying and mar-
eting in favor of the supposed harmlessness of tobacco – going
o far as to show Santa Claus with a cigarette (Fig. 4). A pioneer
f the anti-smoking campaign, Dr Doll, then decided to under-
ake a 40-year follow-up study of 40,000 British physicians who
moked, and found that half of them succumbed to their lethal
abit [28]. This demonstration was backed up by epidemiological
ata highlighting an association between smoking and incidence
f mortality due to lung cancer, especially in women and including
on-smokers whose husbands smoked [4,29]. In 1961, the Kennedy
dministration set up a Smoking and Health Advisory Commit-
ee, whose report formally implicated smoking in the etiology of
ung and laryngeal cancer and chronic bronchitis. The American
edical Association, heavily inﬁltrated by the tobacco industry,
ook 14 years to come round to these conclusions [4]. In 1969, the
anadian Medical Association acknowledged a causal relationshipco ads.
between smoking and lung cancer [3]. In France, as of the 1970s the
National Academy of Medicine published reports formally indict-
ing smoking [1]. Research then began to show that merely passive
smoking causes more deaths from cardiac causes than from lung
cancer, that the overall risk of death is related to the number of
cigarettes smoked per day, and that the mortality risk pattern of
smokers who have stopped for at least 10 years is identical to that
of non-smokers [1,3,4,29–31]. A range of laws and regulations then
began progressively restricting advertising and the public places in
which smoking is allowed (not in aircraft, bars, restaurants, high-
schools, universities, museums, stations, the work-place, and so on)
in Western countries, with campaigns to raise public awareness
of the addiction and cause life-threatening diseases that cigarettes
cause [1,3,31]. In 1992, the US Food and Drug Administration classi-
ﬁed tobacco smoke as being carcinogenic in humans (like radon and
asbestos) [3]. And in 1996 Pr Tubiana, a pioneer of French oncology,
wrote that “If tobacco were discovered today, it would automat-
ically be banned. That it is used at all is an accident of history”
[12].
Although a 1951 ad for a famous brand of cigarettes claimed that
they did not “scratch” the throat [3], many studies throughout the
20th century reported the harmful ENT effects of smoking; these
are related not to nicotine but to the solid particles (tar) and car-
bon monoxide released by combustion and which blend within the
smoke, causing a variety of smoking-related pathologies (Table 1).
More than 50 solid particles (including nitrosamines) found in
tobacco smoke constitute risk factors for squamous cell carcinoma
not only of the larynx but also of the oral cavity, oropharynx and
nasopharynx [32,33]. The pipe-loving Frederick II of Prussia died of
throat cancer, as did Puccini, while the cigar-smoking Freud died of
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Table  1
Diagrammatic classiﬁcation of the impact of various tobacco smoke components on the pathological states induced by smoking.
“Active” combustion products




Addiction 0 + 0 +
Rhinitis, pharyngitis, laryngitis, gingivitis + 0 0 +
Upper airway and lung cancer + 0 0 +
Other cancers: stomach, pancreas, bladder, liver,
kidney, cervix, colon, prostate, skin
+ 0 0 0
Chronic bronchitis + + + +
Cardiovascular pathologies: angina pectoris,
infarction, high blood pressure, heart failure,
stroke, aortic aneurysm, arteritis, thromboembolic
pathologies
+ + + 0
Gastro-esophageal reﬂux, peptic ulcer + + 0 0
Skin  aging + + + 0
Erectile dysfunction, impaired fertility + + + 0
Osteoporosis + + + 0
Pathologies of pregnancy: ectopic pregnancy,
gestational diabetes, preeclampsia, prematurity,
hematoma and hemorrhage at delivery, retarded













































: recognized impact; 0: no recognized impact.
ral cancer. Irritant combustion products (acetone, phenols, hydro-
yanic acid) degrade respiratory mucosa and promote upper airway
nfection, especially in children [3]. Carbon monoxide, formed by
ncomplete combustion of carbon, has the property of binding onto
emoglobin in the place of oxygen, reducing oxygen levels in the
lood and organs; to combat the resulting hypoxia, heart rate and
lood pressure increase, reducing effort capacity and increasing
ardiovascular risk [3]. In the ﬁeld of otorhinolaryngology, this
ascular involvement impairs a number of sensory functions. For
xample, recurrence of sudden deafness is more common in smok-
rs [34,35]; so is balance disorder, while smoking counteracts or
bolishes the effect of vertigo treatments [36,37]. Finally, smoking
amages olfactory nerve endings in the ethmoid; olfactory thresh-
lds are often elevated in smokers, including passive smokers [38].
ikewise, electrogustometric thresholds are elevated: both smell
nd taste are impaired by smoking.
The medical dangers established by the 21st century (Table 1)
re not the only factors weighing in the balance against smok-
ng in Western countries. The tobacco industry’s secret archives
ere thrown open in the lawsuits against the industry in the US,
evealing that nicotine concentrations were intentionally adjusted
nd that some ﬁrms resorted to genetically modiﬁed tobacco and
eveloped nicotine-elevated strains [3,4]. Moreover, a variety of
dditives were put in cigarette tobacco and the pH of the smoke
as adjusted to increase and accelerate the rush of nicotine to
he brain while at the same time making the smoke feel less
ggressive, improving the smoker’s comfort and thereby enhanc-
ng consumption [3,4]. Additives include ammonia, to enhance
icotine absorption, cocoa to dilate the respiratory pathways, and
enol and menthol to mask irritation by their soothing properties
3,4]. Independent experts recently analyzed studies ordered by the
ndustry and performed and published in 2002, which claimed that
igarette additives were harmless [39]; in contrast to the indus-
ry’s published ﬁndings, additives in fact signiﬁcantly increased
he addictive and toxic effects of cigarette smoke [39]. On top of
uch questions of transparency and ethics, there is the ecological
ssue of how the processing and drying of tobacco leaf contributes
o global deforestation and its consequences [3,40]. Governments
ow realize, moreover, the exorbitant costs smoking incurs for soci-
ty. In 2012 in France, the national audit ofﬁce estimated that, while
igarettes bring in D15 billion a year in income, smoking costs soci-
ty D47 billion, including D12 bn in national health insurance outlay
41]. Likewise in the USA, smoking-related public health costs are
stimate at $52 billion, or more than $100 billion if productivitylosses are taken into account [3]. Despite sworn statements made
by the 17 CEOs of American tobacco multinationals before the
House of Representatives in 1994 afﬁrming the harmlessness of
tobacco, a Florida jury 2 years later awarded $750,000 to Grady
Carter and his wife in a product liability suit against the Brown &
Williamson Tobacco Co. [1,3,4]. Fourteen States went on to sue the
industry for public health costs implicating smoking [3,4]. In the
same year, the tobacco majors were forced into an agreement with
the Federal government, guaranteeing their survival up to 2020 in
exchange for severe ﬁnancial penalties [4]. This was only the begin-
ning of a dogged struggle in the American courts against the legal
tricks the industry deployed, at great cost to itself, to get round the
law [4]. On top of all of these tricks, in 2004, Hon Lik, Chinese phar-
macist, invented the electronic cigarette which is presently eating
further into the market.
4. Conclusion
Looking at the number of deaths attributable to tobacco during
the 20th and early 21st centuries, smoking incontestably emerges
as the most lethal epidemic humanity has ever had to face: nearly 6
million deaths per year worldwide – plus whatever assessment can
be envisaged of the illnesses and disabilities caused [42]. The voices
calling out for the freedom to smoke may  be growing fainter, but
the ﬁnancial interests at stake, for industry and all too often for the
state, are such that anything goes to keep this hemorrhage of money
and human lives ﬂowing. In 2008, governments harvested $167 bil-
lion in taxes on tobacco and spent just $965 million on the ﬁght
against smoking [1,4]. For these reasons, the international commu-
nity is not very outspoken when it comes to mortality forecasts for
Asia and Africa, where the epidemic will be most devastating in
coming years. Some statisticians predict the end of smoking in the
West by 2130: in scientiﬁc congresses on the ﬁght against smoking,
talk of an “end-game” is growing. But will it be the same elsewhere?
Cigarette smoking is a scourge the consequences of which outstrip
those of all other addictions put together, and respect for individ-
ual freedom should not serve as a decoy. As Marc Kirsch put it:
“Smoking is not a private matter, and probably never was” [1].Disclosure of interest
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